Healthcare legislation firm Frier Levitt has analyzed FDA enforcement steps in opposition to “study only” peptide vendors. Their summary: the FDA considers a product’s classification based upon its meant use, not its disclaimers. When Sites consist of dosage guides, reconstitution instructions, or connection to discussion boards talking about